Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    UnitedHealth Group

    NYSE: UNH · Real-Time Price · USD
    309.54
    38.05 (14.02%)
    At close: Aug 15, 2025, 12:22 PM

    UnitedHealth Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 421.18B 407.42B 396.63B 390.25B 383.43B 378.48B 371.62B 359.98B 348.51B 335.94B 324.16B 315.12B 306.56B 297.55B 287.6B 279.32B 272.1B 262.92B
    Cost of Revenue
    		 334.69B 319.89B 310.88B 303.81B 294.99B 288.2B 280.66B 270.14B 262.11B 252.78B 244.54B 238.8B 232.96B 226.48B 217.94B 211.49B 205.96B 193.93B
    Gross Profit
    		 86.48B 87.53B 85.75B 86.44B 88.44B 90.27B 90.96B 89.84B 86.4B 83.16B 79.62B 76.32B 73.6B 71.07B 69.65B 67.83B 66.14B 68.99B
    Operating Income
    		 30.75B 33.48B 32.29B 32.2B 32.02B 32.2B 32.36B 31.56B 30.5B 29.57B 28.43B 27.09B 25.34B 24.18B 23.97B 21.95B 20.89B 24.15B
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 26.59B 28.18B 20.07B 20.14B 20.22B 21.78B 29.11B 28.47B 27.72B 27.16B 26.34B 25.24B 23.58B 22.48B 22.31B 20.32B 19.28B 22.52B
    Net Income
    		 21.3B 22.11B 14.4B 14.32B 14.1B 15.36B 22.38B 21.69B 21.11B 20.7B 20.12B 19.43B 18.25B 17.45B 17.29B 15.43B 14.51B 16.88B
    Selling & General & Admin
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 55.73B 54.05B 53.46B 54.24B 56.42B 58.07B 58.6B 58.28B 55.91B 53.59B 51.18B 49.23B 48.26B 46.89B 45.68B 45.88B 45.26B 44.84B
    Operating Expenses
    		 55.73B 54.05B 53.46B 54.24B 56.42B 58.07B 58.6B 58.28B 55.91B 53.59B 51.18B 49.23B 48.26B 46.89B 45.68B 45.88B 45.26B 44.84B
    Interest Expense
    		 4.1B 4.06B 3.91B 3.73B 3.49B 3.34B 3.25B 3.09B 2.77B 2.41B 2.09B 1.85B 1.75B 1.7B 1.66B 1.63B 1.6B 1.62B
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 390.43B 373.94B 364.34B 358.04B 351.41B 346.27B 339.26B 328.42B 318.02B 306.37B 295.73B 288.03B 281.23B 273.37B 263.63B 257.38B 251.21B 238.77B
    Income Tax Expense
    		 4.5B 5.24B 4.83B 5.01B 5.3B 5.63B 5.97B 6.09B 6B 5.89B 5.7B 5.32B 4.85B 4.58B 4.58B 4.42B 4.32B 5.24B
    Shares Outstanding (Basic)
    		 910M 918M 927M 923M 921M 920M 924M 926M 930M 932M 934M 935M 935M 939M 941M 942M 943M 944M
    Shares Outstanding (Diluted)
    		 910M 918M 927M 930M 928M 922M 935M 936M 940M 943M 947M 948M 950M 954M 955M 955M 956M 957M
    EPS (Basic)
    		 23.19 24.03 15.59 15.51 15.26 16.57 24.12 23.32 22.64 22.17 21.50 20.73 19.44 18.54 18.34 16.35 15.35 17.82
    EPS (Diluted)
    		 23.08 23.88 15.50 15.35 15.08 16.36 23.84 23.04 22.35 21.87 21.19 20.42 19.15 18.27 18.08 16.12 15.14 17.59
    EBITDA
    		 35.95B 36.4B 28.08B 27.9B 27.71B 29.12B 36.33B 35.54B 34.3B 33.15B 31.84B 30.27B 28.49B 27.31B 27.07B 25.01B 23.87B 27.07B
    EBIT
    		 31.73B 32.24B 23.98B 23.87B 23.71B 25.12B 32.36B 31.56B 30.5B 29.57B 28.43B 27.09B 25.34B 24.18B 23.97B 21.95B 20.89B 24.15B
    Depreciation & Amortization
    		 4.23B 4.16B 4.1B 4.03B 4B 4B 3.97B 3.98B 3.8B 3.58B 3.4B 3.19B 3.16B 3.13B 3.1B 3.06B 2.99B 2.93B

    Add to Watchlist